13F filerCIK 1061768 ↗

Baupost Group

You are looking at Q4 2023. See the latest, Q3 2026 →

Reported value

$4.59B

−12% on the quarter before

Positions

23

2 new, 11 sold out

Top 10

83.6%

of the value

Est. gain

+$520.2M

on stocks held all quarter

Est. return

+16.9%

on those stocks since Q3 2023

Filed

Feb 13, 2024

On SEC EDGAR ↗

Positions as of Dec 31, 2023, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2023. Striped tiles are options.

Liberty Global Ltd17%
Viasat Inc9.9%
Liberty Media Corp Del9.3%
Alphabet9.1%
Fidelity Natl Information Sv8.3%
Willis Towers Watson Plc Ltd8.2%
Warner Bros Discovery Inc6.3%
Clarivate Plc5.2%
Liberty Media Corp Del5.1%
Crh Plc5.0%
Liberty Global Ltd2.8%
Jazz Pharmaceuticals Plc2.2%
Jacobs Solutions Inc2.1%
Theravance Biopharma Inc1.8%
Tower Semiconductor Ltd1.8%
Liberty Media Corp Del1.5%
Ss&C Technologies Hldgs Inc1.4%
0.7%
0.6%
0.6%
0.6%

Largest buys

Since Q3 2023, sized at quarter-end prices.

  1. Liberty Global Ltd~$788.7MNew, 0.0% → 17.2% of the portfolio+42,311,011 shares
  2. Liberty Global Ltd~$127.8MNew, 0.0% → 2.8% of the portfolio+7,194,276 shares
  3. Jacobs Solutions Inc~$31.2MAdded, 1.3% → 2.1% of the portfolio+240,000 shares
  4. Clarivate Plc~$27.8MAdded, 2.9% → 5.2% of the portfolio+3,000,000 shares
  5. Jazz Pharmaceuticals Plc~$19.7MAdded, 1.7% → 2.2% of the portfolio+160,000 shares

Largest sells

Since Q3 2023, sized at quarter-end prices.

  1. Liberty Global Plc~$785.3MSold out, 15.1% → 0.0% of the portfolio−42,311,011 shares
  2. Veritiv Corp~$561.5MSold out, 10.8% → 0.0% of the portfolio−3,324,324 shares
  3. Alphabet~$124.3MCut, 9.7% → 9.1% of the portfolio−882,000 shares
  4. Liberty Global Plc~$123.2MSold out, 2.4% → 0.0% of the portfolio−7,194,276 shares
  5. Dollar Gen Corp New~$98.1MSold out, 1.9% → 0.0% of the portfolio−927,000 shares
  6. Qorvo~$89.3MSold out, 1.7% → 0.0% of the portfolio−935,612 shares
  7. Ss&C Technologies Hldgs Inc~$77.6MCut, 2.3% → 1.4% of the portfolio−1,270,091 shares
  8. Coinbase~$70.7MSold out, 1.4% → 0.0% of the portfolio−93,750,000 shares
  9. New Oriental Ed & Technology~$59.9MSold out, 1.1% → 0.0% of the portfolio−1,023,272 shares
  10. Liberty Media Corp Del~$44.3MCut, 1.2% → 0.6% of the portfolio−1,184,202 shares

Holdings

As of Dec 31, 2023; changes in shares since Sep 30, 2023.

Positions, sorted by share of the portfolio
HoldingValue
Liberty Global LtdCOM CL C · shares New17.2%$788.7M—
Viasat IncCOM · shares 0% · price +51.4%9.9%$452.1M+$153.5M
Liberty Media Corp DelCOM LBTY SRM S C · shares 0% · price +13.0%9.3%$427.4M+$49.3M
AlphabetCAP STK CL C · shares −23% · price +6.9%9.1%$415.7M+$26.8M
Fidelity Natl Information SvCOM · shares −8.6% · price +8.7%8.3%$382.1M+$30.5M
Willis Towers Watson Plc LtdSHS · shares 0% · price +15.4%8.2%$375.2M+$50.2M
Warner Bros Discovery IncCOM SER A · shares 0% · price +4.8%6.3%$287.2M+$13.1M
Clarivate PlcORD SHS · shares +13% · price +38.0%5.2%$236.1M+$57.4M
Liberty Media Corp DelCOM LBTY SRM S A · shares 0% · price +12.9%5.1%$235.0M+$26.9M
Crh PlcORD · shares 0% · price +26.4%5.0%$231.4M+$48.3M
Liberty Global LtdCOM CL A · shares New2.8%$127.8M—
Jazz Pharmaceuticals PlcSHS USD · shares +24% · price −5.0%2.2%$102.5M−$4.3M
Jacobs Solutions IncCOM · shares +49% · price −4.9%2.1%$94.5M−$3.3M
Theravance Biopharma IncCOM · shares 0% · price +30.2%1.8%$83.4M+$19.4M
Tower Semiconductor LtdSHS NEW · shares −4.9% · price +24.3%1.8%$82.7M+$16.2M
Liberty Media Corp DelCOM LBTY LIV S A · shares −4.0% · price +14.5%1.5%$69.4M+$8.8M
Ss&C Technologies Hldgs IncCOM · shares −55% · price +16.3%1.4%$62.9M+$8.8M
Gray Television IncCOM · shares 0% · price +29.5%0.73%$33.7M+$7.7M
Garrett Motion IncCOM · shares −50% · price +22.7%0.63%$29.0M+$5.4M
Liberty Media Corp DelCOM LBTY LIV S C · shares −62% · price +16.5%0.59%$26.9M+$3.8M
Herbalife LtdCOM SHS · shares −0.8% · price +9.1%0.56%$25.6M+$2.1M
Altice Usa IncCL A · shares 0% · price −0.6%0.34%$15.5M−$96,000
Finch Therapeutics Group IncCOM NEW · shares 0% · price −30.4%0.01%$243,000−$106,000
Total 23 positions100%$4.59B+$520.2M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2023 to Q4 2023: 21 stocks held throughout, up $520.2M (+16.9%).

  1. Viasat Inc+$153.5M+51%
  2. Clarivate Plc+$57.4M+38%
  3. Willis Towers Watson Plc Ltd+$50.2M+15%
  4. Liberty Media Corp Del+$49.3M+13%
  5. Crh Plc+$48.3M+26%
  6. Altice Usa Inc−$96,000−1%
  7. Finch Therapeutics Group Inc−$106,000−30%
  8. Jacobs Solutions Inc−$3.3M−5%
  9. Jazz Pharmaceuticals Plc−$4.3M−5%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$20.00B$10.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$5.05B−7%SEC ↗
Q2 2026$5.42B+6%SEC ↗
Q1 2026$5.12B−3%SEC ↗
Q4 2025$5.28B+10%SEC ↗
Q3 2025$4.79B+16%SEC ↗
Q2 2025$4.13B+18%SEC ↗
Q1 2025$3.50B+2%SEC ↗
Q4 2024$3.43B−2%SEC ↗
Q3 2024$3.52B−3%SEC ↗
Q2 2024$3.63B−0%SEC ↗
Q1 2024$3.65B−20%SEC ↗
Q4 2023$4.59B−12%SEC ↗
Q3 2023$5.21B−7%SEC ↗
Q2 2023$5.61B−4%SEC ↗
Q1 2023$5.85B−5%SEC ↗
Q4 2022$6.13B+6%SEC ↗
Q3 2022$5.79B−14%SEC ↗
Q2 2022$6.77B−27%SEC ↗
Q1 2022$9.30B−8%SEC ↗
Q4 2021$10.13B−7%SEC ↗
Q3 2021$10.88B−12%SEC ↗
Q2 2021$12.33B−2%SEC ↗
Q1 2021$12.56B+16%SEC ↗
Q4 2020$10.84B+17%SEC ↗
Q3 2020$9.25B+15%SEC ↗
Q2 2020$8.01B+18%SEC ↗
Q1 2020$6.77B−25%SEC ↗
Q4 2019$9.06B+3%SEC ↗
Q3 2019$8.83B−20%SEC ↗
Q2 2019$11.05B−7%SEC ↗
Q1 2019$11.90B+3%SEC ↗
Q4 2018$11.52B−12%SEC ↗
Q3 2018$13.06B+14%SEC ↗
Q2 2018$11.44B+10%SEC ↗
Q1 2018$10.37B+3%SEC ↗
Q4 2017$10.11B+26%SEC ↗
Q3 2017$8.02B−8%SEC ↗
Q2 2017$8.75B+3%SEC ↗
Q1 2017$8.49B+11%SEC ↗
Q4 2016$7.67B+9%SEC ↗
Q3 2016$7.04B−4%SEC ↗
Q2 2016$7.37B+6%SEC ↗
Q1 2016$6.92BSEC ↗

Subscribe to TheInference for free